hematopoietic system
• mice show a reduction in the number of plaque-associated myeloid cells compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice, indicating an impairment in myeloid cell accumulation around plaques
|
• proliferation of myeloid cells is reduced compared to levels in single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
|
homeostasis/metabolism
• mice show a 31% and 36% reduction in compact fibrillary, thioflavin S positive plaque number and percent area, respectively, in the hippocampus compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice, indicating altered plaque structure
• however, the total number of cortical plaques and percent area is similar to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
• mice show a decrease in soluble amyloid beta 1-40 in the cortex and thus an increased ratio of amyloid beta 42/40 compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
|
nervous system
• mice show a 31% and 36% reduction in compact fibrillary, thioflavin S positive plaque number and percent area, respectively, in the hippocampus compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice, indicating altered plaque structure
• however, the total number of cortical plaques and percent area is similar to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
• mice show a decrease in soluble amyloid beta 1-40 in the cortex and thus an increased ratio of amyloid beta 42/40 compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
|
• marker analysis indicates increased plaque-associated neuritic dystrophy compared to single transgenic Tg(Thy1-APPSw,Thy1-PSEN1*L166P)21Jckr mice
|